ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced it will display and demonstrate products and technologies from the company’s arrhythmia management portfolio at the 15th annual Boston Atrial Fibrillation (BAF) Symposium. The featured products reflect the company’s continued commitment to the treatment of abnormal heart rhythms, including Atrial Fibrillation (AF).
